Random anti-Mullerian hormone predicts ovarian response in women with high baseline follicle-stimulating hormone levels Anti-Mullerian hormone in poor responders in assisted reproductive treatment

Creative Commons License

Çelik H., Bildircin D., Güven D., Cetinkaya M. B., Alper T., Batuoglu A. S.

JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, cilt.29, sa.8, ss.797-802, 2012 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 29 Sayı: 8
  • Basım Tarihi: 2012
  • Doi Numarası: 10.1007/s10815-012-9794-y
  • Dergi Adı: JOURNAL OF ASSISTED REPRODUCTION AND GENETICS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.797-802
  • Anahtar Kelimeler: Anti-Mullerian hormone, Follicle-stimulating hormone, Diminished ovarian reserve, IN-VITRO FERTILIZATION, ANTIMULLERIAN HORMONE, RESERVE, AMH
  • Ondokuz Mayıs Üniversitesi Adresli: Evet

Özet

To evaluate the predictive value of random serum anti-Mullerian hormone (AMH) in the assessment of ovarian response in patients with diminished ovarian reserve (DOR; diagnosed after the observation of elevated baseline levels of early follicular follicle-stimulating hormone [FSH]) who were undergoing intracytoplasmic sperm injection-embryo transfer (ICSI-ET) and to compare the random serum AMH and baseline FSH levels in these patients for the prediction of poor ovarian response.